Health Minister announces pharmacist committee members for the National Medicines Policy review, set to begin in August
Two pharmacists will join the committee for the National Medicines Policy review, Minister for Health and Aged Care Greg Hunt announced at PSA21 conference on Friday.
Pharmacists Professor Lloyd Sansom AO and Dr Sarah Dineen-Griffin will team up with consumer advocate Janette Donovan and pharmaceutical industry expert David Herd to form the expert advisory committee.
It will be chaired by Professor Michael Kidd, the Commonwealth’s Deputy Chief Medical Officer.
Professor Sansom is a special advisor to the Commonwealth Department of Health, and Dr Dineen-Griffin is a clinical pharmacist researcher and this year’s NSW Early Career Pharmacist of the Year.
The National Medicines Policy, published in 2000, will undergo the review from August with the aim of “ensuring Australia’s NMP remains fit for purpose and relevant to the medicines landscape”.
Quality Use of Medicines (QUM) is one of the central objectives of the National Medicines Policy.
Minister Hunt has previously promised that the review will include quality use of medicines and medicines safety as part of its broad scope.
“The review will provide options to Government on how to modernise this policy, improve medicines use and safety, strengthen health technology assessment processes, and ensure ongoing timely, safe and affordable access to medicines for all Australians,” he said.
PSA National President Chris Freeman thanked Minister Hunt for officially opening this year’s annual flagship conference.
“This Committee brings expertise in medicines policy, clinical practice, consumer engagement, and the pharmaceutical industry to the review,” said A/Prof Freeman.
“PSA looks forward to working closely with the committee to ensure medicines safety and quality use of medicines are strengthened as a central pillar of the National Medicines Policy.”